Trial intelligence / Profile preview

Topical intranasal cocaine vs tetracaine + oxymetazoline vs ropivacaine + oxymetazoline for FESS

NL-OMON32081Not yet recruiting

Sponsor
Canisius-Wilhelmina Hospital
Start
Jul 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label trial of cocaine, tetracaine, oxymetazoline and ropivacaine in chronic rhinosinusitis with nasal polyps (CRSwNP) and Nasal mucosal edema, sponsored by Canisius-Wilhelmina Hospital. Planned start Jul 2008; status: not yet recruiting.

02

Drugs

cocainetetracaineoxymetazolineropivacaine
03

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)Nasal mucosal edema

Beyond the preview

Go deeper on NL-OMON32081.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32081.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call